RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer. - Wikidata - awgldk - TriplyDB

RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.

RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.

http://www.wikidata.org/entity/Q40545042

about

Repair Injured Heart by Regulating Cardiac Regenerative Signals RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer.Emerging role of Hippo signalling pathway in bladder cancer.YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression.The prognostic impacts of TEA domain (TEAD) transcription factor polymorphisms in Chinese hepatocellular carcinoma patients.Identification of a novel YAP-14-3-3ζ negative feedback loop in gastric cancer.Generation of RUNX3 knockout pigs using CRISPR/Cas9-mediated gene targeting.Transcriptional regulation by RUNX3 RUNX3 regulates YAP1-mediated transcription TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.Roles of RUNX in Hippo Pathway Signaling.DNA binding partners of YAP/TAZ.RUNX3 binds TEADs and YAP1 TEADs:YAP1 binds CTGF gene Roles of RUNX in Solid Tumors.PIWIL1/piRNA-DQ593109 Regulates the Permeability of the Blood-Tumor Barrier via the MEG3/miR-330-5p/RUNX3 Axis.RUNX1 and RUNX3 protect against YAP-mediated EMT, stem-ness and shorter survival outcomes in breast cancer.

P2860

Q28066930-7257430B-E6D2-4276-9BB3-6DA23254D9E8 Q36079567-0F8D1C45-DDFD-4D69-9F95-EA33D1BD9450 Q37190507-67A969A7-7235-4473-84E9-9591DE2E6308 Q38637679-0CC08EFB-AE4D-4651-A2DC-07AA6860C3C7 Q41389363-6B61C882-0BD4-4639-9A40-5557A8A61CD8 Q42378384-7D06390F-7A2D-492E-ADAE-F157F1AD85D3 Q42700861-E4676DE1-8135-47B3-9007-D3537066504C Q45044138-2CD6558B-9FED-4211-A2EE-21CF02ACB7ED Q45316828-1776B9D8-8794-4F69-A7CA-BC02A4C308DC Q45316834-C56AFECD-A8D9-4D00-868B-122F2BF2A950 Q47126606-E82B67FE-35E4-4940-89B9-7038507E3656 Q47944350-4CF65312-5917-40D8-853E-B52F25F2BC17 Q49797899-0548406C-99D2-4D20-9621-F8A08D6C8BD5 Q50290763-6EF2CC4B-1BE0-4F62-9D0C-B9569DAF9B95 Q50290764-D0537421-61E5-4064-A865-58F59F9F5EDA Q50796410-7A4CDC3B-9050-4999-842E-2E13CBAAEB71 Q52369044-EA723F32-A984-4691-A5C4-F693E4327DE5 Q55262723-6FE819B4-7352-4B71-9D95-64FBD6325B29

P2860

RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.

http://www.wikidata.org/entity/Q40545042

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.

@en

type

label

RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.

@en

prefLabel

RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.

@en

P1433

Q40545042-59841A47-5DE8-4964-906C-E42FA21C1A0E

P1476

Q40545042-E1487147-BDF7-4775-B7C4-71A2533D49F2

P2093

Q40545042-0AA45DFF-4F1C-4173-BE92-58CE820C6BEB

Q40545042-13659872-9B19-4561-A8DB-27F25CB9477E

Q40545042-1F62946B-FE77-4D45-9B0D-A2BFCB194E90

Q40545042-2303E506-5FCC-4717-9623-A2952FFB1867

Q40545042-327FECCF-C0CA-4A23-B002-CE4B9B1B0506

Q40545042-3DD82C87-44FF-40A9-96C4-D915F5BF845E

Q40545042-5E4A3983-539C-4C6A-A05E-BFD1310FF9D3

Q40545042-7C690567-D770-4E96-B62E-5B3D1B9A49AB

Q40545042-97405C4F-33FE-4657-8122-68CAFE90E7D3

Q40545042-BB86881C-C877-404D-BB36-70198CB4199A

P2860

Q40545042-0121E57B-3C21-432C-809E-73EF09E44490

Q40545042-06E89199-D227-4CF7-801B-0DAE87133634

Q40545042-11009B00-D734-4AB0-B8C9-102CE44E6F23

Q40545042-15DF063E-DC86-4FDC-8874-88166323BBCE

Q40545042-1B2573CA-8620-44C3-8022-3FF6F7646B1C

Q40545042-22D7A046-D0CA-4D95-AD94-7C74B39E1D28

Q40545042-28C72C25-3D9E-4202-AD0A-FD3B09CAFC69

Q40545042-2AC50097-3940-4764-B832-5B9F85C11E9C

Q40545042-2DA526C7-7787-4871-B4D4-32D2228B5646

Q40545042-2E0F8517-E5C9-4050-B93E-CFA20B29CE98

P2888

Q40545042-02282EFF-BAD4-4CBB-B7B1-51845FF843E3

P304

Q40545042-031D8B23-8EBE-4F24-95CB-B2CA53908D91

P31

Q40545042-F4BCFED1-AFF2-4F52-AAA6-1EA9484B4819

P356

Q40545042-07CE4CA5-175F-4918-9EF4-DF9938C26C1E

P407

Q40545042-C7F29F87-601A-4CC3-9606-6A4D2135F233

P433

Q40545042-6BC66D33-3733-48EE-9DB6-8B4C0BEC052B

P478

Q40545042-32E9B2F1-7132-4021-84BB-2BA50B22751B

P577

Q40545042-825D8982-CD06-4C98-BEA2-4508DAAE39B8

P6179

Q40545042-A9466C64-6091-4EFF-BBDC-F67510895ABC

P698

Q40545042-35293FE9-1C81-468C-A7BA-190D9A6511C0

P356

P1433

P1476

RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.

@en

P2093

D C-C Voon

http://www.w3.org/2001/XMLSchema#string

F Zhu

http://www.w3.org/2001/XMLSchema#string

K G Yeoh

http://www.w3.org/2001/XMLSchema#string

L S H Chuang

http://www.w3.org/2001/XMLSchema#string

M Sudol

http://www.w3.org/2001/XMLSchema#string

P Tan

http://www.w3.org/2001/XMLSchema#string

S C Lee

http://www.w3.org/2001/XMLSchema#string

S J Lin

http://www.w3.org/2001/XMLSchema#string

T Wang

http://www.w3.org/2001/XMLSchema#string

Y Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Role of scaffold protein afadin dilute domain-interacting protein (ADIP) in platelet-derived growth factor-induced cell movement by activating Rac protein through Vav2 protein

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response

RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis

SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action

Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules

TEAD mediates YAP-dependent gene induction and growth control

A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer

Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma

P2888

P304

2664-2674

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2015.338

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1005462977

http://www.w3.org/2001/XMLSchema#string

P698

26364597

http://www.w3.org/2001/XMLSchema#string